In vivo, transgenic miceexpressing porcine TRPC1 (Tg-pTRPC1) on a HFD were used as obesity models to explore the potential effect of TRPC1 on fat deposition, hepatic steatosis, glucose metabolism, and insulin sensitivity. The gene discussed is INS; the disease is obesity disorder.